NAB

1.34%

$39.22 national australia bank limited

And no one talks about the prevalence or not, of antibodies in...

First 153 Last

Share
Profile

Follow
Kaddles

546 Posts.

55

20/10/20

13:14

Post #: 48234148
Share

Originally posted by pe981: ↑

The Covid vaccine talk has ben hi jacked by politicians who talk up the prospects of an imminent breakthrough while the medical profession maintains a much more cautious approach. Clinical trials are exactly that and trying to assess efficacy before completion is pointless.
When (and if) a vaccine is discovered (and approved) there will still be a considerable lead time for the manufacture, distribution and vaccinations . Not sure that Australia will be at the head of the line as manufacturers ramp up production however putting in place supply arrangements early is a sensible move.
There will be considerable pressure around the world as to how any vaccine is rolled out and we may see it directed to where it is most needed!!
A treatment drug may be a better bet shorter term which would allow communities to have confidence of living with the virus with a greatly reduced death rate and no risk of overloading hospitals from break outs.
Of course, any announcement of approval of a vaccine or effective treatment will certainly improve market sentiment however at the end of the day the actual performance of any company will be what counts.
As our economy opens, the actual fall out from the lock downs will be laid bare. For banks it will mean they will need to address distressed loans and over the next 12+ months they will probably have to crystalise expected losses. SP may then be under a bit of pressure if the real losses start rising more than expected and provisioned. Banks will also be under pressure if the economy takes a while to start the next growth phase.
It should be noted that while our international borders are essentially closed they are still operating for trade, so large parts of the economy are operating as normal. Obviously there are specific industries just about decimated including tourism (intn) and education while many small businesses in Australia may fall by the wayside based on regional lock downs and lack of work.
Our banks remain in a privileged position and while earnings may be under pressure in the coming couple of years as the country recovers they still have a sound fundamental earnings base which is the main reason I was only focusing on how NAB is performing in the here and now and what that might mean.
Just my take on it.............

Expand

And no one talks about the prevalence or not, of antibodies in the general population. After this length of time we should have an idea of what levels of natural resistance exists in the community (herd immunity). If we are testing for the virus surely we have an understanding of the incidence of antibodies.

NAB Price at posting: $19.34 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

First 153 Last

Add NAB (ASX) to my watchlist

(20min delay)
Last $39.22		Change 0.520(1.34%)		Mkt cap ! $120.5B

Open	High	Low	Value	Volume
$38.80	$39.22	$38.56	$164.9M	4.223M

Buyers (Bids)

No.	Vol.	Price($)
1	9324	$39.22

Sellers (Offers)

Price($)	Vol.	No.
$39.24	8294	4

View Market Depth

No.	Vol.	Price($)
1	100	39.000
1	20	38.800
1	750	38.750
1	1000	38.730
1	120	38.700

Price($)	Vol.	No.
39.240	373	2
39.250	10547	5
39.280	509	1
39.290	641	1
39.300	18652	5

Last trade - 16.10pm 15/11/2024 (20 minute delay)

NAB (ASX) Chart

And no one talks about the prevalence or not, of antibodies in...

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

And no one talks about the prevalence or not, of antibodies in...

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News